In selected patients with cirrhosis and ascites, transjugular intrahepatic portosystemic shunt
(TIPS) placement improves control of ascites and may reduce mortality. In this review, we …

Transjugular intrahepatic portosystemic shunt (TIPS) is an established treatment tool in
decompensated liver cirrhosis that has been shown to prolong transplant-free survival …

Portal hypertension (PH) constitutes a pivotal factor in the progression of cirrhosis, giving
rise to severe complications and a diminished survival rate. The transjugular intrahepatic …

Abstract Background The Freiburg index of post-TIPS survival (FIPS) score was recently
demonstrated to improve prediction of post-TIPS mortality relative to existing standards. As …

Objective: Body tissue composition plays a crucial role in the multisystemic processes of
advanced liver disease and has been shown to be influenced by transjugular intrahepatic …

Purpose The purpose of this study was to make a systematic review and meta-analysis to
determine the stent diameter (8 mm vs. 10 mm) that conveys better safety and clinical …

Background In light of the global rise in the burden of chronic liver diseases and liver
cirrhosis, the number of patients suffering from decompensation events is expected to …

Hepatic encephalopathy (HE) is a challenging complication after transjugular intrahepatic
portosystemic shunt (TIPS) placement. Despite recent advances, much is still uncertain …

Malnutrition is a tangible complication of cirrhosis with portal hypertension with a prevalence
of up to 50%. In particular, sarcopenia and myosteatosis, defined as the alteration in muscle …

Since 1988, transjugular intrahepatic portosystemic shunt (TIPS) has been an effective
therapy for portal hypertension in many settings. Thanks to continuous technical …